Explore Watchlists Pricing

SYSMEX CORPORATION (6869) Balance sheet

Market cap

¥889.1B

P/E ratio

24.4x

Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	50,272	56,544	25,545	23,613	51,062	56,592	66,467	73,752	69,460	75,507	89,570	84,117
Marketable securities, current	-	240	299	-	214	7,644	421	1,105	1,498	875	1,310	654	775
Accounts receivable, net	-	53,038	55,505	-	72,567	84,247	85,650	100,641	118,697	126,319	157,067	163,007	168,783
Inventories	-	22,737	27,056	13,028	13,886	40,231	48,303	46,985	61,944	73,310	79,123	81,811	95,613
Total current assets	-	154,148	172,665	88,893	93,993	195,423	205,704	230,833	275,092	295,491	343,459	364,821	388,606
Property, plant and equipment, net	-	59,061	61,235	30,273	34,680	76,312	96,839	96,140	98,525	102,106	116,693	130,211	150,396
Marketable securities, non-current	-	7,174	6,753	4,197	5,321	7,050	6,192	7,945	9,157	9,777	14,034	12,034	14,025
Total non-current assets	-	93,835	94,973	101,153	118,244	151,352	183,586	196,641	208,614	235,583	275,461	300,447	318,925
Total assets	-	247,983	267,638	190,046	321,979	346,775	389,291	427,475	483,707	531,074	618,920	665,268	707,532
Accounts payable	-	15,965	19,873	-	28,579	29,778	33,917	34,159	32,111	31,678	33,602	31,865	34,116
Short-term debt	-	14,061	12,311	7,050	7,607	806	552	1,529	1,482	3,537	1,028	1,403	1,316
Total current liabilities	-	65,170	65,895	36,096	45,107	71,247	84,145	89,907	102,082	111,102	118,084	122,826	119,259
Total non-current liabilities	-	13,262	13,646	1,181	825	10,345	26,798	28,898	32,571	31,615	67,938	77,908	82,596
Total liabilities	-	78,432	79,542	37,278	80,536	81,592	110,944	118,806	134,654	142,718	186,023	200,734	201,856
Retained earnings	-	129,703	155,562	121,848	134,017	241,445	261,321	279,477	305,710	334,192	365,985	402,820	416,253
Stockholders' equity	146,250	169,550	188,095	152,768	166,305	265,182	278,347	308,669	349,053	388,356	432,897	464,534	278,685
Working capital	-			-